Our research goals include 1) identification and mechanism studies of small molecule drug candidates for target proteins including immune receptor TREM2 to regulate important cellular activities in Alzheimer's disease, cancer, vascular and infection disease, regenerative medicine and other neurodegenerative diseases, with current focus in Alzheimer's disease, using integrated computational bioengineering, computational biology and experimental approaches. 2) Determining drug candidates to compensate loss of protein functions by diseases-associated genetic variants for precision and personalized medicine.
University of Alabama at Birmingham
Birmingham, Alabama, USA
Department of Biomedical Engineering
University Educator/Researcher
University of Alabama at Birmingham, Birmingham, USA
01 Aug 2006 - present